Scandinavian Biopharma announces the last follow up visit in the phase IIB clinical trial with ETVAX® in Finnish travellers to Benin

In record time Scandinavian Biopharma completed a phase IIB randomized, double-blind, placebo-controlled trial in Finnish travellers going to Benin in West Africa. All participants have now been enrolled and the last travellers left Benin in March 2019. The last follow up visit was conducted just before Easter. In total 743 healthy travellers, between the ages […]

Scandinavian Biopharma officially starts their late phase development program in Africa funded by EDCTP

The Permanent Secretary at Ministry of Health Dr Kennedy Malama together with the Swedish Ambassador Henrik Cederin, Dr Izukanji Sikazwe CEO at Centre for Infectious Disease Research in Zambia (CIDRZ) and Dr Godfrey Biemba CEO at National Health Research Authority (NHRA) in Zambia officially announced April 17th the start of Scandinavian Biopharma’s late phase paediatric […]

Scandinavian Biopharma recruits Madelene Franzén as Accounting Manager

Scandinavian Biopharma continues to expand and now welcomes Madelene Franzén as Accounting Manager. Madelene has previously been an authorized accounting consultant and will be responsible for Scandinavian Biopharma’s accounts. Madelene most recently comes from Björn Borg AB, where she worked as Senior Accountant. Madelene has also worked as an authorized accounting consultant for Wahlgren’s book-keeping […]